chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 40.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Dizziness, Headache, Nausea
Clinical narrative: This case was received on 11 May 2012 via a third party query tool search on the VAERS database, under reference number 449199. A 40-year-old male patient received the following vaccination on 25 January 2012: ACAM2000 (lot number VV04-003-A). On 06 February 2012, the patient experienced dizziness, headache and nausea. The patient was hospitalized (dates not reported). The patient took no other medications, had no current illnesses and no history. The patient's outcome was recovered. Documents held by sender: None.
Age: 24.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Activities of daily living impaired, Headache, Loss of consciousness, Malaise, Pain
Clinical narrative: This case was received on 11 May 2012 via a third party query tool search on the VAERS database, under the reference number 449243. A 24-year-old male patient received the following vaccination on 11 March 2009: ACAM2000 (lot number VV04-003-A). On the same day, the patient experienced was unable to do "take check one week later" and further stated that he was unable to do anything for 3 days as a result of fever, general malaise, body aches, headaches: he does not recall that timeframe stating "I was unconscious for 3 days but was unable to go to hospital because my roommate was out of town". The patient had a PPD placed on 11 March 2009, anthrax was given on 02 February 2009 and 11 February 2009. The patient had no current illnesses and had a history of peanut allergy age 8-9 where he experienced hives, runny eyes and no shortness of breath (SOB)/loss of consciousness (LOC). The patient's outcome was recovered. Documents held by sender: None.
Age: 24.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Pyrexia
Clinical narrative: This case was received on 11 May 2012 via a third party query tool search on the VAERS database, under the reference number 449243. A 24-year-old male patient received the following vaccination on 11 March 2009: ACAM2000 (lot number VV04-003-A). On the same day, the patient experienced was unable to do "take check one week later" and further stated that he was unable to do anything for 3 days as a result of fever, general malaise, body aches, headaches: he does not recall that timeframe stating "I was unconscious for 3 days but was unable to go to hospital because my roommate was out of town". The patient had a PPD placed on 11 March 2009, anthrax was given on 02 February 2009 and 11 February 2009. The patient had no current illnesses and had a history of peanut allergy age 8-9 where he experienced hives, runny eyes and no shortness of breath (SOB)/loss of consciousness (LOC). The patient's outcome was recovered. Documents held by sender: None.
Age: 21.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Influenza like illness, Rash pustular, Scab
Clinical narrative: This case was received on 11 May 2012 via a third party query tool search on the VAERS database, under reference number 449575. A 21-year-old male patient received a right arm percutaneous injection of ACAM2000, SP Biologics Co., lot number VV04-003-A on 01 February 2012. Thirteen days later, on 14 February 2012, the patient developed two crusted pustules on face both less that (<) five millimeter (mm) size (coded as: rash pustular and scab), and he experienced Flu like symptoms (coded as influenza like illness). The patient required an emergency visit. The patient's history was reported as none and current illness were reported as unknown. No laboratory data or treatments were reported. The patient's outcome was reported as recovered (date not reported). Documents held by sender: none.
Age: 19.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Rash erythematous, Rash generalised, Rash papular, Rash pruritic, Skin plaque
Clinical narrative: This case was received on 11 May 2012 via a third party query tool search on the VAERS database, under reference number 450110. A 19-year-old female patient received the following vaccination on 03 February 2012: ACAM2000 (lot number VV04-003-A). On 18 February 2012, the patient experienced "numerous small scattered erythematous papules, many with vesicle - spread across entire body, pruritic, some coalescing on the hands and large erythematous almost purple plaques on both heels". The patient had an emergency visit and was hospitalized (dates not reported). Other medications included levonorgestrel/ethinyl estradiol. The patient had no current illnesses and a history of lactose intolerance and presumed celiac disease. The patient's outcome was not recovered. Documents held by sender: None.
Age: 19.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Rash generalised, Rash papular, Rash pruritic, Rash vesicular, Skin plaque
Clinical narrative: This case was received on 11 May 2012 via a third party query tool search on the VAERS database, under reference number 450110. A 19-year-old female patient received the following vaccination on 03 February 2012: ACAM2000 (lot number VV04-003-A). On 18 February 2012, the patient experienced "numerous small scattered erythematous papules, many with vesicle - spread across entire body, pruritic, some coalescing on the hands and large erythematous almost purple plaques on both heels". The patient had an emergency visit and was hospitalized (dates not reported). Other medications included levonorgestrel/ethinyl estradiol. The patient had no current illnesses and a history of lactose intolerance and presumed celiac disease. The patient's outcome was not recovered. Documents held by sender: None.
Age: 26.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Injection site erythema, Nodule, Vaccination site nodule, Vaccination site pustule
Clinical narrative: This case was received on 11 May 2012 via a third party query tool search on the VAERS database, under reference number 450363. A 26-year-old female patient received a left arm percutaneous injection of ACAM2000, SP Biologics Co., lot number VV04-003-A on 26 February 2011. On 12 February 2012, 351 days later, the patient developed red pustule like nodules on outer aspect of left arm near smallpox vaccine site. More nodules appeared over the past two weeks and have been note on the right arm as well. The patient was examined by a physician. The patient's medical history and current illnesses was reported as none. No laboratory data or treatments were reported. The patient's outcome was reported as recovery unknown. Documents held by sender: None.
Age: 26.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Nodule, Vaccination site erythema, Vaccination site nodule, Vaccination site pustule
Clinical narrative: This case was received on 11 May 2012 via a third party query tool search on the VAERS database, under reference number 450363. A 26-year-old female patient received a left arm percutaneous injection of ACAM2000, SP Biologics Co., lot number VV04-003-A on 26 February 2011. On 12 February 2012, 351 days later, the patient developed red pustule like nodules on outer aspect of left arm near smallpox vaccine site. More nodules appeared over the past two weeks and have been note on the right arm as well. The patient was examined by a physician. The patient's medical history and current illnesses was reported as none. No laboratory data or treatments were reported. The patient's outcome was reported as recovery unknown. Documents held by sender: None.
Age: 29.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Blood creatine phosphokinase MB increased, Blood creatine phosphokinase normal, Chest discomfort, Troponin T
Clinical narrative: This case was received on 11 May 2012 via a third party query tool search on the VAERS database, under reference number 450397. A 29-year-old male patient received the following vaccinations on 07 February 2012: ACAM2000 (lot number VV04-003-A), TYPHIM Vi (sanofi pasteur SA, lot number E0576), BIOTHRAX (EMERGENT, lot number FAV296). On 19 February 2012, the patient experienced chest discomfort and elevated troponin was detected on 21 February 2012. The patient was admitted to the hospital later the same day. An emergency visit was also required. Laboratory results on 21 February 2012 included kinase MB serum 3.0 ng/mL; creatine kinase mb index serum NPP, at 10:22: troponin T cardiac serum 0.038 (H*) ng/mL at 21:50: creatine kinase serum 155 U/L, creatine kinase MB serum 2.6 ng/ml, troponin T cardiac serum 0.038 (H*) ng/mL, on 22 February 2012 at 03:50: creatine kinase serum 139 U/L, creatine kinase MB serum 2.4 ng/mL, troponin T cardiac serum 0.027 ng/mL, at 16:51: creatine kinase serum 116 U/L, creatine kinase MB serum 2.0 ng/mL, troponin T cardiac serum <0.010 ng/mL. The patient took no other medications, had no current illnesses, had no known drug allergies (NKDA), no medical conditions and no congenital defects. The patient's outcome was recovered. Documents held by sender: None.
Age: 29.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Blood creatine phosphokinase MB increased, Blood creatine phosphokinase normal, Chest discomfort, Troponin T increased
Clinical narrative: This case was received on 11 May 2012 via a third party query tool search on the VAERS database, under reference number 450397. A 29-year-old male patient received the following vaccinations on 07 February 2012: ACAM2000 (lot number VV04-003-A), TYPHIM Vi (sanofi pasteur SA, lot number E0576), BIOTHRAX (EMERGENT, lot number FAV296). On 19 February 2012, the patient experienced chest discomfort and elevated troponin was detected on 21 February 2012. The patient was admitted to the hospital later the same day. An emergency visit was also required. Laboratory results on 21 February 2012 included kinase MB serum 3.0 ng/mL; creatine kinase mb index serum NPP, at 10:22: troponin T cardiac serum 0.038 (H*) ng/mL at 21:50: creatine kinase serum 155 U/L, creatine kinase MB serum 2.6 ng/ml, troponin T cardiac serum 0.038 (H*) ng/mL, on 22 February 2012 at 03:50: creatine kinase serum 139 U/L, creatine kinase MB serum 2.4 ng/mL, troponin T cardiac serum 0.027 ng/mL, at 16:51: creatine kinase serum 116 U/L, creatine kinase MB serum 2.0 ng/mL, troponin T cardiac serum <0.010 ng/mL. The patient took no other medications, had no current illnesses, had no known drug allergies (NKDA), no medical conditions and no congenital defects. The patient's outcome was recovered. Documents held by sender: None.
Age: 29.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Chest pain, Echocardiogram, Electrocardiogram normal, Troponin I, Troponin normal
Clinical narrative: This case was received on 11 May 2012 via a third party query tool search on the VAERS database, under reference number 450397. A 29-year-old male patient received the following vaccinations on 07 February 2012: ACAM2000 (lot number VV04-003-A), TYPHIM Vi (sanofi pasteur SA, lot number E0576), BIOTHRAX (EMERGENT, lot number FAV296). On 19 February 2012, the patient experienced chest discomfort and elevated troponin was detected on 21 February 2012. The patient was admitted to the hospital later the same day. An emergency visit was also required. Laboratory results on 21 February 2012 included kinase MB serum 3.0 ng/mL; creatine kinase mb index serum NPP, at 10:22: troponin T cardiac serum 0.038 (H*) ng/mL at 21:50: creatine kinase serum 155 U/L, creatine kinase MB serum 2.6 ng/ml, troponin T cardiac serum 0.038 (H*) ng/mL, on 22 February 2012 at 03:50: creatine kinase serum 139 U/L, creatine kinase MB serum 2.4 ng/mL, troponin T cardiac serum 0.027 ng/mL, at 16:51: creatine kinase serum 116 U/L, creatine kinase MB serum 2.0 ng/mL, troponin T cardiac serum <0.010 ng/mL. The patient took no other medications, had no current illnesses, had no known drug allergies (NKDA), no medical conditions and no congenital defects. The patient's outcome was recovered. Documents held by sender: None.
Age: 26.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Blood creatine phosphokinase MB normal, Blood creatine phosphokinase normal, Chest pain, Echocardiogram abnormal, Electrocardiogram PR interval
Clinical narrative: This case was received on 11 May 2012 via a third party query tool search on the VAERS database, under reference number 450530. A 26 year-old male patient had received a left arm injection of ACAM2000 (lot number not reported) on 08 January 2012 and 29 days later on 06 February 2012, experienced sudden onset of pleuritic chest pain that was "unaccompanied by dyspnea, orthopnea, edema or significant limitations in exercise capacity". The patient was evaluated in the emergency room. The patient had a normal EKG with the exception of subtle ST elevation (~1mm) and PR depression (~0.5mm) in lead AVF and was a normal sinus rhythm (NSR) in the low 60s without ectopy or conduction disturbances. A transthoracic echocardiogram showed a 1.5 cm pericardial effusion without evidence of RV collapse or tamponade. Laboratory tests included a normal CK, CK-MB and Troponin I. The patient's final diagnosis was vaccinia-associated pericarditis. Treatment included indomethacin with "good relief". The patient's current illnesses and history were reported as none. The patient was not admitted. No further information was available at the time of the report. The patient's outcome was recovered. A corrective version was created on 12 September 2012 with the same latest received date of the previous version for the purpose of amending the seriousness for the event of pericarditis to serious. No new medical information was received. Documents held by sender: none.
Age: 26.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Electrocardiogram ST segment elevation, Electrocardiogram abnormal, Pericardial effusion, Pericarditis, Pleuritic pain
Clinical narrative: This case was received on 11 May 2012 via a third party query tool search on the VAERS database, under reference number 450530. A 26 year-old male patient had received a left arm injection of ACAM2000 (lot number not reported) on 08 January 2012 and 29 days later on 06 February 2012, experienced sudden onset of pleuritic chest pain that was "unaccompanied by dyspnea, orthopnea, edema or significant limitations in exercise capacity". The patient was evaluated in the emergency room. The patient had a normal EKG with the exception of subtle ST elevation (~1mm) and PR depression (~0.5mm) in lead AVF and was a normal sinus rhythm (NSR) in the low 60s without ectopy or conduction disturbances. A transthoracic echocardiogram showed a 1.5 cm pericardial effusion without evidence of RV collapse or tamponade. Laboratory tests included a normal CK, CK-MB and Troponin I. The patient's final diagnosis was vaccinia-associated pericarditis. Treatment included indomethacin with "good relief". The patient's current illnesses and history were reported as none. The patient was not admitted. No further information was available at the time of the report. The patient's outcome was recovered. A corrective version was created on 12 September 2012 with the same latest received date of the previous version for the purpose of amending the seriousness for the event of pericarditis to serious. No new medical information was received. Documents held by sender: none.
Age: 26.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Troponin I
Clinical narrative: This case was received on 11 May 2012 via a third party query tool search on the VAERS database, under reference number 450530. A 26 year-old male patient had received a left arm injection of ACAM2000 (lot number not reported) on 08 January 2012 and 29 days later on 06 February 2012, experienced sudden onset of pleuritic chest pain that was "unaccompanied by dyspnea, orthopnea, edema or significant limitations in exercise capacity". The patient was evaluated in the emergency room. The patient had a normal EKG with the exception of subtle ST elevation (~1mm) and PR depression (~0.5mm) in lead AVF and was a normal sinus rhythm (NSR) in the low 60s without ectopy or conduction disturbances. A transthoracic echocardiogram showed a 1.5 cm pericardial effusion without evidence of RV collapse or tamponade. Laboratory tests included a normal CK, CK-MB and Troponin I. The patient's final diagnosis was vaccinia-associated pericarditis. Treatment included indomethacin with "good relief". The patient's current illnesses and history were reported as none. The patient was not admitted. No further information was available at the time of the report. The patient's outcome was recovered. A corrective version was created on 12 September 2012 with the same latest received date of the previous version for the purpose of amending the seriousness for the event of pericarditis to serious. No new medical information was received. Documents held by sender: none.
Age: 26.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Blood creatine phosphokinase MB normal, Blood creatine phosphokinase normal, Echocardiogram abnormal, Electrocardiogram PR interval, Electrocardiogram ST segment elevation
Clinical narrative: This case was received on 11 May 2012 via a third party query tool search on the VAERS database, under reference number 450530. A 26 year-old male patient had received a left arm injection of ACAM2000 (lot number not reported) on 08 January 2012 and 29 days later on 06 February 2012, experienced sudden onset of pleuritic chest pain that was "unaccompanied by dyspnea, orthopnea, edema or significant limitations in exercise capacity". The patient was evaluated in the emergency room. The patient had a normal EKG with the exception of subtle ST elevation (~1mm) and PR depression (~0.5mm) in lead AVF and was a normal sinus rhythm (NSR) in the low 60s without ectopy or conduction disturbances. A transthoracic echocardiogram showed a 1.5 cm pericardial effusion without evidence of RV collapse or tamponade. Laboratory tests included a normal CK, CK-MB and Troponin I. The patient's final diagnosis was vaccinia-associated pericarditis. Treatment included indomethacin with "good relief". The patient's current illnesses and history were reported as none. The patient was not admitted. No further information was available at the time of the report. The patient's outcome was recovered. A corrective version was created on 12 September 2012 with the same latest received date of the previous version for the purpose of amending the seriousness for the event of pericarditis to serious. No new medical information was received. Documents held by sender: none.
Age: 26.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Electrocardiogram abnormal, Pericardial effusion, Pericarditis, Pleuritic pain, Troponin I
Clinical narrative: This case was received on 11 May 2012 via a third party query tool search on the VAERS database, under reference number 450530. A 26 year-old male patient had received a left arm injection of ACAM2000 (lot number not reported) on 08 January 2012 and 29 days later on 06 February 2012, experienced sudden onset of pleuritic chest pain that was "unaccompanied by dyspnea, orthopnea, edema or significant limitations in exercise capacity". The patient was evaluated in the emergency room. The patient had a normal EKG with the exception of subtle ST elevation (~1mm) and PR depression (~0.5mm) in lead AVF and was a normal sinus rhythm (NSR) in the low 60s without ectopy or conduction disturbances. A transthoracic echocardiogram showed a 1.5 cm pericardial effusion without evidence of RV collapse or tamponade. Laboratory tests included a normal CK, CK-MB and Troponin I. The patient's final diagnosis was vaccinia-associated pericarditis. Treatment included indomethacin with "good relief". The patient's current illnesses and history were reported as none. The patient was not admitted. No further information was available at the time of the report. The patient's outcome was recovered. A corrective version was created on 12 September 2012 with the same latest received date of the previous version for the purpose of amending the seriousness for the event of pericarditis to serious. No new medical information was received. Documents held by sender: none.
Age: 26.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Troponin normal
Clinical narrative: This case was received on 11 May 2012 via a third party query tool search on the VAERS database, under reference number 450530. A 26 year-old male patient had received a left arm injection of ACAM2000 (lot number not reported) on 08 January 2012 and 29 days later on 06 February 2012, experienced sudden onset of pleuritic chest pain that was "unaccompanied by dyspnea, orthopnea, edema or significant limitations in exercise capacity". The patient was evaluated in the emergency room. The patient had a normal EKG with the exception of subtle ST elevation (~1mm) and PR depression (~0.5mm) in lead AVF and was a normal sinus rhythm (NSR) in the low 60s without ectopy or conduction disturbances. A transthoracic echocardiogram showed a 1.5 cm pericardial effusion without evidence of RV collapse or tamponade. Laboratory tests included a normal CK, CK-MB and Troponin I. The patient's final diagnosis was vaccinia-associated pericarditis. Treatment included indomethacin with "good relief". The patient's current illnesses and history were reported as none. The patient was not admitted. No further information was available at the time of the report. The patient's outcome was recovered. A corrective version was created on 12 September 2012 with the same latest received date of the previous version for the purpose of amending the seriousness for the event of pericarditis to serious. No new medical information was received. Documents held by sender: none.
Age: 24.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Dermatitis acneiform, Injection site reaction, Malaise, Pruritus, Pyrexia
Clinical narrative: This case was received on 11 May 2012 via a third party query tool search on the VAERS database, under reference number 450562. A 24-year-old male patient received the following vaccinations on 13 February 2012: ACAM2000 (lot number VV04-003-A), TYPHIM VI (lot number B1026) and BIOTHRAX (lot number FAV305). On 22 February 2012, the patient reported intermittent fever up to 102 degrees, increased rash, increased pruritus and malaise "time 3 days". On exam, the patient had prominent acneiform appearing rash with areas of confluences, especially around inoculation site. Rash spares hands, feet, head and neck. The assessment was robust take in immunocompetent male. The plan was BENADRYL and TYLENOL as needed (prn) and Prednisone taper. The patient will return in 3 days or sooner if needed. No laboratory tests were ordered at this visit. The patient had no current illnesses, no past medical history and took no other medications. The patient's outcome was unknown. Documents held by sender: None.
Age: 24.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Rash
Clinical narrative: This case was received on 11 May 2012 via a third party query tool search on the VAERS database, under reference number 450562. A 24-year-old male patient received the following vaccinations on 13 February 2012: ACAM2000 (lot number VV04-003-A), TYPHIM VI (lot number B1026) and BIOTHRAX (lot number FAV305). On 22 February 2012, the patient reported intermittent fever up to 102 degrees, increased rash, increased pruritus and malaise "time 3 days". On exam, the patient had prominent acneiform appearing rash with areas of confluences, especially around inoculation site. Rash spares hands, feet, head and neck. The assessment was robust take in immunocompetent male. The plan was BENADRYL and TYLENOL as needed (prn) and Prednisone taper. The patient will return in 3 days or sooner if needed. No laboratory tests were ordered at this visit. The patient had no current illnesses, no past medical history and took no other medications. The patient's outcome was unknown. Documents held by sender: None.
Age: 24.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Rash, Robust take following exposure to vaccinia virus
Clinical narrative: This case was received on 11 May 2012 via a third party query tool search on the VAERS database, under reference number 450562. A 24-year-old male patient received the following vaccinations on 13 February 2012: ACAM2000 (lot number VV04-003-A), TYPHIM VI (lot number B1026) and BIOTHRAX (lot number FAV305). On 22 February 2012, the patient reported intermittent fever up to 102 degrees, increased rash, increased pruritus and malaise "time 3 days". On exam, the patient had prominent acneiform appearing rash with areas of confluences, especially around inoculation site. Rash spares hands, feet, head and neck. The assessment was robust take in immunocompetent male. The plan was BENADRYL and TYLENOL as needed (prn) and Prednisone taper. The patient will return in 3 days or sooner if needed. No laboratory tests were ordered at this visit. The patient had no current illnesses, no past medical history and took no other medications. The patient's outcome was unknown. Documents held by sender: None.
Age: 23.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Chills, Cough, Diarrhoea, Headache, Malaise
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 450874. A 23-year-old male patient received the following vaccinations on 22 February 2012: ACAM2000 (lot number not reported) and BIOTHRAX (lot number FAV305). On 23 February 2012, the patient had a fever of 103.3F, body aches, malaise, nausea, intermittent headaches, chills, mild cough and diarrhea. The event required an emergency room visit and hospitalization. The patient had an incidental finding of neutropenia when presented to the emergency department (ED) and a past medical history of herpes esophagitis. The patient's other medications included VALTREX and sucralfate. No further information was available at the time of the report. The patient's outcome was unknown. Documents held by sender: None.
Age: 23.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Nausea, Pain, Pyrexia
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 450874. A 23-year-old male patient received the following vaccinations on 22 February 2012: ACAM2000 (lot number not reported) and BIOTHRAX (lot number FAV305). On 23 February 2012, the patient had a fever of 103.3F, body aches, malaise, nausea, intermittent headaches, chills, mild cough and diarrhea. The event required an emergency room visit and hospitalization. The patient had an incidental finding of neutropenia when presented to the emergency department (ED) and a past medical history of herpes esophagitis. The patient's other medications included VALTREX and sucralfate. No further information was available at the time of the report. The patient's outcome was unknown. Documents held by sender: None.
Age: 19.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Injection site discharge, Injection site erythema, Injection site pruritus, Injection site pustule, Injection site reaction
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 450992. A 19-year-old female patient received the following vaccination on 21 February 2012: ACAM2000 (lot number VV04-003-A). Ten days post smallpox vaccination (SPV), the patient had multiple lesions around primary site on left arm that began about seven days ago and have not changed much. The patient was feeling well. The patient had some enlarged lymph nodes left axilla and redness around lesions. The lesions are draining so that she changes the dressing twice daily (bid). The patient also had mild itching, pain, no trauma , fever, chills, chest pain and shortness of breath (SOB). No history of eczema, psoriasis or other skin disorder. No history of any medical problems and has always been very healthy. The patient had dermatitis due to drugs and medicines generalized: autoinoculation. The patient appeared very well with twelve pustules in the same stage on the left deltoid that vary in size from eraser-size to 1/2 dime in a cluster 1 1/2 x 3 inches that are tan with no reported change in color. Mild erythema was spreading 3 inches below and 1-2 inches on sides and top. Site care was reviewed need for extra caution with the excess drainage including good hand washing. The patient had a medical reactive exemption for future SPV immunizations. No lab data was provided. The patient had no current illnesses and no past medical history. The patient's outcome was not reported. Documents held by sender: None.
Age: 19.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Lymphadenopathy, Skin lesion
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 450992. A 19-year-old female patient received the following vaccination on 21 February 2012: ACAM2000 (lot number VV04-003-A). Ten days post smallpox vaccination (SPV), the patient had multiple lesions around primary site on left arm that began about seven days ago and have not changed much. The patient was feeling well. The patient had some enlarged lymph nodes left axilla and redness around lesions. The lesions are draining so that she changes the dressing twice daily (bid). The patient also had mild itching, pain, no trauma , fever, chills, chest pain and shortness of breath (SOB). No history of eczema, psoriasis or other skin disorder. No history of any medical problems and has always been very healthy. The patient had dermatitis due to drugs and medicines generalized: autoinoculation. The patient appeared very well with twelve pustules in the same stage on the left deltoid that vary in size from eraser-size to 1/2 dime in a cluster 1 1/2 x 3 inches that are tan with no reported change in color. Mild erythema was spreading 3 inches below and 1-2 inches on sides and top. Site care was reviewed need for extra caution with the excess drainage including good hand washing. The patient had a medical reactive exemption for future SPV immunizations. No lab data was provided. The patient had no current illnesses and no past medical history. The patient's outcome was not reported. Documents held by sender: None.
Age: 19.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Dermatitis, Injection site discharge, Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 450992. A 19-year-old female patient received the following vaccination on 21 February 2012: ACAM2000 (lot number VV04-003-A). Ten days post smallpox vaccination (SPV), the patient had multiple lesions around primary site on left arm that began about seven days ago and have not changed much. The patient was feeling well. The patient had some enlarged lymph nodes left axilla and redness around lesions. The lesions are draining so that she changes the dressing twice daily (bid). The patient also had mild itching, pain, no trauma , fever, chills, chest pain and shortness of breath (SOB). No history of eczema, psoriasis or other skin disorder. No history of any medical problems and has always been very healthy. The patient had dermatitis due to drugs and medicines generalized: autoinoculation. The patient appeared very well with twelve pustules in the same stage on the left deltoid that vary in size from eraser-size to 1/2 dime in a cluster 1 1/2 x 3 inches that are tan with no reported change in color. Mild erythema was spreading 3 inches below and 1-2 inches on sides and top. Site care was reviewed need for extra caution with the excess drainage including good hand washing. The patient had a medical reactive exemption for future SPV immunizations. No lab data was provided. The patient had no current illnesses and no past medical history. The patient's outcome was not reported. Documents held by sender: None.
Age: 19.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Injection site pustule, Injection site reaction, Lymphadenopathy, Post vaccination autoinoculation, Skin lesion
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 450992. A 19-year-old female patient received the following vaccination on 21 February 2012: ACAM2000 (lot number VV04-003-A). Ten days post smallpox vaccination (SPV), the patient had multiple lesions around primary site on left arm that began about seven days ago and have not changed much. The patient was feeling well. The patient had some enlarged lymph nodes left axilla and redness around lesions. The lesions are draining so that she changes the dressing twice daily (bid). The patient also had mild itching, pain, no trauma , fever, chills, chest pain and shortness of breath (SOB). No history of eczema, psoriasis or other skin disorder. No history of any medical problems and has always been very healthy. The patient had dermatitis due to drugs and medicines generalized: autoinoculation. The patient appeared very well with twelve pustules in the same stage on the left deltoid that vary in size from eraser-size to 1/2 dime in a cluster 1 1/2 x 3 inches that are tan with no reported change in color. Mild erythema was spreading 3 inches below and 1-2 inches on sides and top. Site care was reviewed need for extra caution with the excess drainage including good hand washing. The patient had a medical reactive exemption for future SPV immunizations. No lab data was provided. The patient had no current illnesses and no past medical history. The patient's outcome was not reported. Documents held by sender: None.
Age: 29.0
Sex: M
Vaccine: ANTH, DTP, HEPA, SMALL, ANTH, HEPA, SMALL, TDAP
Symptoms: Erythema, Infection, Robust take following exposure to vaccinia virus, Skin warm, Vaccination site swelling
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 451084. A 29-year-old male patient received the following vaccinations on 19 February 2012: ACAM2000 (lot number VV04-003-A), ADACEL (lot number C3989AA), HAVRIX (lot number AHAVB443AB) and BIOTHRAX (lot number FAV305). On an unspecified date after vaccination, the patient experienced robust take versus secondary infection, increased redness and warmth extending to elbow, swelling of entire upper arm and vaccine site was approx. 3cm in diameter on day 14. The patient's other medications included CLEOCIN, ZYRTEC, BENADRYL and MOTRIN. The patient had no current illnesses and a past medical history of G6PD deficiency. The patient's outcome was unknown. Documents held by sender: None.
Age: 29.0
Sex: M
Vaccine: ANTH, DTP, HEPA, SMALL, ANTH, HEPA, SMALL, TDAP
Symptoms: Infection, Injection site erythema, Robust take following exposure to vaccinia virus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 451084. A 29-year-old male patient received the following vaccinations on 19 February 2012: ACAM2000 (lot number VV04-003-A), ADACEL (lot number C3989AA), HAVRIX (lot number AHAVB443AB) and BIOTHRAX (lot number FAV305). On an unspecified date after vaccination, the patient experienced robust take versus secondary infection, increased redness and warmth extending to elbow, swelling of entire upper arm and vaccine site was approx. 3cm in diameter on day 14. The patient's other medications included CLEOCIN, ZYRTEC, BENADRYL and MOTRIN. The patient had no current illnesses and a past medical history of G6PD deficiency. The patient's outcome was unknown. Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Eschar, Scab, Vaccination complication
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 451112. A 20-year-old male patient received the following vaccination on 22 February 2012: ACAM2000 (lot number VV04-003-A). On 04 March 2012, the patient had secondary inoculation approximately 1/2" inferior to the patients left lower lip from the vermilion border. Eschar appears to be healing at the same stage as the primary vaccine. The patient first noticed the sore and self applied PROACTIV cream (thinking it was acne) then the following morning the sore was scabbed and appeared healing normally. The patient had no current illnesses and no past medical history. The patient's outcome was recovered. Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Eschar, Post vaccination autoinoculation, Scab
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 451112. A 20-year-old male patient received the following vaccination on 22 February 2012: ACAM2000 (lot number VV04-003-A). On 04 March 2012, the patient had secondary inoculation approximately 1/2" inferior to the patients left lower lip from the vermilion border. Eschar appears to be healing at the same stage as the primary vaccine. The patient first noticed the sore and self applied PROACTIV cream (thinking it was acne) then the following morning the sore was scabbed and appeared healing normally. The patient had no current illnesses and no past medical history. The patient's outcome was recovered. Documents held by sender: None.
Age: 45.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Chest pain, Echocardiogram, Electrocardiogram normal, Lumbar puncture, Nuclear magnetic resonance imaging
Clinical narrative: This study case was received from an investigator in a trial on 22 February 2012. A 45 year-old male subject with a past medical history of elevated cholesterol and diabetes (Type I or Type II) was found to have on 23 April 2009 "other, chest pain" three days after the subject had received on 20 April 2009 the following vaccines: ACAM2000 (lot number, route and site of administration not reported), an injection of TYPHIM VI (lot number, route and site of administration not reported) and ANTHRAX 1 (manufacturer, lot number, route and site of administration not reported). Relevant laboratory data included: a normal Troponin I on 24 April 2009 and a normal ECG on 27 April 2009. Echocardiogram, Lumbar puncture and MRI of the brain, spinal cord and heart were not available. Treatments were not reported. Additional information will be requested from the investigator. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Documents held by sender: none.
Age: 45.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Nuclear magnetic resonance imaging brain, Troponin I
Clinical narrative: This study case was received from an investigator in a trial on 22 February 2012. A 45 year-old male subject with a past medical history of elevated cholesterol and diabetes (Type I or Type II) was found to have on 23 April 2009 "other, chest pain" three days after the subject had received on 20 April 2009 the following vaccines: ACAM2000 (lot number, route and site of administration not reported), an injection of TYPHIM VI (lot number, route and site of administration not reported) and ANTHRAX 1 (manufacturer, lot number, route and site of administration not reported). Relevant laboratory data included: a normal Troponin I on 24 April 2009 and a normal ECG on 27 April 2009. Echocardiogram, Lumbar puncture and MRI of the brain, spinal cord and heart were not available. Treatments were not reported. Additional information will be requested from the investigator. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Documents held by sender: none.
Age: 45.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Chest pain, Echocardiogram, Electrocardiogram normal, Lumbar puncture, Nuclear magnetic resonance imaging brain
Clinical narrative: This study case was received from an investigator in a trial on 22 February 2012. A 45 year-old male subject with a past medical history of elevated cholesterol and diabetes (Type I or Type II) was found to have on 23 April 2009 "other, chest pain" three days after the subject had received on 20 April 2009 the following vaccines: ACAM2000 (lot number, route and site of administration not reported), an injection of TYPHIM VI (lot number, route and site of administration not reported) and ANTHRAX 1 (manufacturer, lot number, route and site of administration not reported). Relevant laboratory data included: a normal Troponin I on 24 April 2009 and a normal ECG on 27 April 2009. Echocardiogram, Lumbar puncture and MRI of the brain, spinal cord and heart were not available. Treatments were not reported. Additional information will be requested from the investigator. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Documents held by sender: none.
Age: 45.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Nuclear magnetic resonance imaging spinal cord, Nuclear magnetic resonance imaging thoracic, Troponin I, Troponin normal
Clinical narrative: This study case was received from an investigator in a trial on 22 February 2012. A 45 year-old male subject with a past medical history of elevated cholesterol and diabetes (Type I or Type II) was found to have on 23 April 2009 "other, chest pain" three days after the subject had received on 20 April 2009 the following vaccines: ACAM2000 (lot number, route and site of administration not reported), an injection of TYPHIM VI (lot number, route and site of administration not reported) and ANTHRAX 1 (manufacturer, lot number, route and site of administration not reported). Relevant laboratory data included: a normal Troponin I on 24 April 2009 and a normal ECG on 27 April 2009. Echocardiogram, Lumbar puncture and MRI of the brain, spinal cord and heart were not available. Treatments were not reported. Additional information will be requested from the investigator. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Documents held by sender: none.
Age: 33.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Chest pain, Cough
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 451184. A 33-year-old female patient received the following vaccination on 02 March 2012: ACAM2000 (lot number not reported). On 04 March 2012, the patient experienced right side chest pain and dry cough. The patient had no current illnesses and no past medical history. The patient took no concomitant medications. The patient's outcome was unknown. Documents held by sender: None.
Age: 25.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Rash papular, Viral test
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 451193. A 25-year-old male patient received the following vaccination on 15 February 2012: ACAM2000 (VV04-003-A). The patient experienced a papulovesicular vaccinia reaction that onset in the morning of 03 March 2012. The rash worsened and led to emergency department evaluation and subsequent hospital admission on 04 March 2012. The patient was discharged on 05 March 2012. The patient's vaccinia culture was pending. The patient took no concomitant medications, no current illnesses and no past medical history. The patient's outcome was recovered. Documents held by sender: None.
Age: 25.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Culture, Rash papular, Vaccination complication
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 451193. A 25-year-old male patient received the following vaccination on 15 February 2012: ACAM2000 (VV04-003-A). The patient experienced a papulovesicular vaccinia reaction that onset in the morning of 03 March 2012. The rash worsened and led to emergency department evaluation and subsequent hospital admission on 04 March 2012. The patient was discharged on 05 March 2012. The patient's vaccinia culture was pending. The patient took no concomitant medications, no current illnesses and no past medical history. The patient's outcome was recovered. Documents held by sender: None.
Age: 29.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Chest pain, Echocardiogram normal, Electrocardiogram abnormal, Troponin I, Troponin I increased
Clinical narrative: This study case was received from the investigator in a trial on 22 February 2012 with additional information received on 28 February 2012. A 29-year-old male subject had received the following vaccinations: On 04 November 2009, an injection of ACAM2000 (lot number not reported). On 03 November 2009, an injection of ANTHRAX (manufacturer and lot number not reported), INFLUENZA, LIVE, INTRANASAL (manufacturer and lot number not reported) and TYPHIM VI, sanofi pasteur SA (lot number not reported). The subject had an abnormal troponin I on 13 November 2009, a normal echocardiogram on 14 November 2009 and an abnormal ECG on 15 November 2009. The subject was diagnosed with chest pain, unspecified on 13 November 2009. The subject had no significant medical history. No further information was available at the time of the report. The subject's outcome was not reported. Note: there is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Follow-up information was received from the investigator on 19 March 2012. Fifteen days post-vaccination, the subject presented to a clinic status post (s/p) four day hospitalization for chest pain (CP) with respiration 3/10, two weeks s/p smallpox vaccine (SPV). Inpatient testing included an ECG that revealed diffuse small ST segment elevations. Cardiac catheterization and enzymes rules out myocardial infarction (MI) and atherosclerotic disease. The subject was asymptomatic and had no prior history of related symptoms. Lungs were clear to auscultation (CTA). Fifteen days post-vaccination, the subject's ECG revealed normal sinus rhythm (NSR), regular rate and rhythm (RRR) and no murmur. "A/P 1) Pericarditis: possibly related to SPV. Resolved." The subject's past medical history (PMH) included testicular cancer, orchidectomy and reflux disease. The subject's family history included cancer on the maternal side. The subject's concomitant medication was "omneprozol." The subject's outcome was recovered. Documents held by sender: None.